病毒
干扰素
医学
免疫学
小RNA
病毒复制
疾病
甲型流感病毒
机制(生物学)
免疫系统
发病机制
病毒学
生物
内科学
基因
哲学
认识论
生物化学
作者
Yanan Xing,Lin Chen,Bin Hu,Yi Li,Huan Mai,Gaojian Li,Shuyi Han,Ye Wang,Yanyi Huang,Ying Tian,Weiguo Zhang,Yan Gao,Hongxuan He
标识
DOI:10.1016/j.omtn.2024.102149
摘要
Patients with pre-existing medical conditions are at a heightened risk of contracting severe acute respiratory syndrome (SARS), SARS-CoV-2, and influenza viruses, which can result in more severe disease progression and increased mortality rates. Nevertheless, the molecular mechanism behind this phenomenon remained largely unidentified. Here, we found that microRNA-19a/b (miR-19a/b), which is a constituent of the miR-17-92 cluster, exhibits reduced expression levels in patients with coronary heart disease in comparison to healthy individuals. The downregulation of miR-19a/b has been observed to facilitate the replication of influenza A virus (IAV). miR-19a/b can effectively inhibit IAV replication by targeting and reducing the expression of SOCS1, as observed in cell-based and coronary heart disease mouse models. This mechanism leads to the alleviation of the inhibitory effect of SOCS1 on the interferon (IFN)/JAK/STAT signaling pathway. The results indicate that the IAV employs a unique approach to inhibit the host's type I IFN-mediated antiviral immune responses by decreasing miR-19a/b. These findings provide additional insights into the underlying mechanisms of susceptibility to flu in patients with coronary heart disease. miR-19a/b can be considered as a preventative/therapy strategy for patients with coronary heart disease against influenza virus infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI